Correspondence to editorials on "Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial"

Clin Mol Hepatol. 2024 Nov 11. doi: 10.3350/cmh.2024.0989. Online ahead of print.
No abstract available

Keywords: Efficacy; HK660S; PSC; Safety.